Cordlife’s six-month suspension to take effect from Dec 15
CORDLIFE’S : P8A 0% six-month suspension by the Ministry of Health (MOH) will take effect from Dec 15, it said on Friday (Dec 15).
During the suspension period, the cord blood banking company will have to cease collecting, testing, processing and/or storing any new cord blood and human tissues. It also cannot provide any new types of tests to patients.
It will also have to work hard to regain the trust of MOH and the public in its internal protocols, processes and standards of clinical governance during the suspension period and thereafter.
Cordlife received the six-month suspension notice from MOH after seven of its 22 cord-blood storage tanks were found to have been kept at temperatures above acceptable limits. These tanks, in deep freeze, held a total of 19,500 cord-blood units belonging to 19,200 clients.
The company had accepted MOH’s suspension notice a day earlier, and said then that it will not make written representations to the ministry on the notice.
Shares of Cordlife closed 4.8 per cent or S$0.015 higher at S$0.325 on Friday, before the announcement.
GET BT IN YOUR INBOX DAILY
Start and end each day with the latest news stories and analyses delivered straight to your inbox.
KEYWORDS IN THIS ARTICLE
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
HSBC brings out tax tools for UK businesses ahead of new rules
Nelson Loh intends to plead guilty to charges including forgery and cheating
Singapore shares edge up at Friday’s open; STI up 0.2%
Data leak reveals links between money laundering accused Su Jianfeng and sale of Dubai properties
‘No better player’ than GIC to help revitalise fortunes of Singapore stock market: observers
Businessmen in Singapore placed on China’s wanted list weeks after money laundering raid in 2023